Mahavir Advanced Remedies (Delisted) share price
BSE: 531689Pharmaceuticals & Biotechnology
Mahavir Advanced Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last traded ₹150.65 on 6 Jan 2015
Delisted on 23 Nov 2023.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Feb 2015
Jan 2015
16 Jan · Management
Mr. Sanjay Kr. Choradia has been appointed as additional Director (Independent) w.e.f. January 15, 2015 subject to approval of Members ....14 Jan · Shareholding Pattern For December 31, 2014
Dec 2014
30 Dec · Change in situation of Registered Office
Registered Office of the Company has been shifted to the following new address w.e.f. December 23, 2014 - Office No. 67/2, ....22 Dec · Change in Registered Office
Registered Office of the Company has been shifted to the following new address w.e.f. November 05, 2014: Office No. 2/1, D-11, ....
Results for the quarter to Dec 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹0.03 Cr+10.7% on a year ago · −75.2% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹0.01 Cr−27.8% on a year ago · −88.0% on the quarter before
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- ₹0.01−50.0% on a year ago · −90.0% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, on the quarter before wherever the profit of that quarter was restated, and across a change of basis named under the table, on the lines it affects.
- Net margin
- 41.9%
From revenue to net profit, ₹ crore
- Revenue0.0
- Profit before tax0.0
- Net profit0.0
Mahavir Advanced Remedies results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2014. Results for the quarter to Mar 2015 were due by 30 May 2015, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹0.13 Cr, quarter to Sep 2014; lowest ₹0.01 Cr, quarter to Dec 2012A loss in 4 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.05 | 0.07 | 0.06 | 0.05 | 0.06 | 0.04 | 0.03 | 0.07 | 0.06 | 0.05 | 0.06 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.13 | 0.03 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | – | 0.04 | 0.04 | 0.04 | 0.04 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.04 | – | – | – | – | – | – | – | 0.04 | – | – | – | – | – | – | – | – | – | – | – |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.22 | – | – | – |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | −0.05 | 0.00 | −0.01 | 0.00 | – | −0.01 | −0.01 | −0.01 | 0.00 | −0.01 | 0.01 | 0.00 | −0.06 | 0.01 | 0.02 | 0.02 | 0.09 | 0.01 | 0.11 | 0.01 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | – | – | – | – | – | – | −0.11 | – | – | – | −0.04 | – | 0.04 | – | – | – |
| Profit before tax | −0.05 | 0.00 | −0.01 | 0.00 | – | −0.01 | −0.01 | −0.01 | 0.00 | −0.01 | −0.10 | 0.00 | −0.06 | 0.01 | −0.02 | 0.02 | 0.13 | 0.01 | 0.11 | 0.01 |
| Tax | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | – | – | – | – | – | – |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | 25.0% | – | – | – | – | – | – |
| Net profit | −0.05 | 0.00 | −0.01 | 0.00 | – | −0.01 | −0.01 | −0.01 | 0.00 | −0.01 | −0.10 | 0.00 | −0.06 | 0.01 | −0.02 | 0.02 | 0.13 | 0.01 | 0.11 | 0.01 |
| Net margin | −117.8% | −4.5% | −8.3% | −1.9% | – | −21.4% | −25.8% | −14.9% | 1.7% | −10.9% | −168.9% | 16.7% | −356.3% | 36.0% | −84.6% | 64.3% | 541.7% | 33.3% | 86.4% | 41.9% |
| Earnings per share | – | – | – | – | – | – | – | – | – | – | −₹0.20 | – | −₹0.05 | ₹0.01 | −₹0.02 | ₹0.02 | ₹0.11 | ₹0.01 | ₹0.10 | ₹0.01 |
Earnings per share in rupees, restated for later splits and bonuses.
7 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Peak revenue ₹0.24 Cr, year to Mar 2011; lowest ₹0.02 Cr, year to Mar 2009Back to profit in the year to Mar 2014, ₹0.14 Cr
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Mar 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue0.1
- Other income+0.2
- Profit before tax0.1
- Net profit0.1
Profit and loss
Standalone, ₹ crore, years to March. The last column is the twelve months to Dec 2014, the latest four quarters added.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Dec 2014Twelve months |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.07 | 0.02 | 0.19 | 0.24 | 0.21 | 0.15 | 0.10 | 0.20 |
| – | – | – | – | – | – | – | – | |
| Materials and goods bought | 0.02 | 0.00 | – | 0.16 | – | – | – | – |
| Depreciation and amortisation | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | – | – | – |
| Other income | – | – | – | – | – | – | 0.22 | – |
| Profit before one-off items and tax | – | −0.10 | −0.06 | −0.05 | −0.02 | −0.04 | 0.14 | 0.22 |
| One-off items | – | – | – | – | – | −0.11 | – | – |
| Profit before tax | −0.09 | −0.10 | −0.06 | −0.05 | −0.02 | −0.15 | 0.14 | 0.26 |
| Net profit | −0.09 | −0.10 | −0.06 | −0.05 | −0.02 | −0.15 | 0.14 | 0.26 |
| Net margin | −125.0% | −577.8% | −32.8% | −19.6% | −8.7% | −105.5% | 134.0% | 127.0% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2008, Mar 2009, Mar 2010, Mar 2011 and Mar 2012: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2013 and Mar 2014: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March.
| Ratio | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | −73.5% | 966.7% | 25.0% | −14.2% | −29.6% | −29.0% |
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2014.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | 41.7% | −24.6% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −6.5% | 6.6% |
Mahavir Advanced Remedies share price by year
Each calendar year to 2015.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2015 | 150.65 | −7.7% | 160.00 | 150.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 6 Jan 2015.
Recent sessions
The 10 trading days to 6 Jan 2015, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 6 Jan 2015 | 150.65 | 150.65 | 150.65 | 150.65 | 150.65 | 4,004 |
| 5 Jan 2015 | 153.70 | 153.70 | 153.70 | 153.70 | 153.70 | 2 |
| 2 Jan 2015 | 156.80 | 156.80 | 156.80 | 156.80 | 156.80 | 2 |
| 1 Jan 2015 | 160.00 | 160.00 | 160.00 | 160.00 | 160.00 | 20 |
| 30 Dec 2014 | 163.25 | 163.25 | 163.25 | 163.25 | 163.25 | 13,100 |
| 26 Dec 2014 | 166.55 | 166.55 | 166.55 | 166.55 | 166.55 | 1 |
| 24 Dec 2014 | 175.30 | 175.30 | 175.30 | 175.30 | 175.30 | 1 |
| 23 Dec 2014 | 184.50 | 184.50 | 184.50 | 184.50 | 184.50 | 1 |
| 22 Dec 2014 | 194.20 | 194.20 | 194.20 | 194.20 | 194.20 | 1 |
| 19 Dec 2014 | 204.40 | 204.40 | 204.40 | 204.40 | 204.40 | 5 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 531689
- ISIN
- INE716N01016
- Industry
- Pharmaceuticals & Biotechnology
- Website
- www.iaap.in
- CIN
- L24231TN1992PLC022562
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1992
- Registered office
- 67/2, Second Floor, III Street, N. M. Road, Chennai 600029, Tamil Nadu
- Share registrar
- Purva Sharegistry (India) Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments